Cargando…
Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
Background: Cancer is the second leading cause of death globally accounting for more than half of deaths in Low- and Middle-Income Countries (LMICs). Cancer treatment is expensive and the high prices of cancer medicines have a huge impact on access in LMICs. Scarcity of pricing or affordability data...
Autores principales: | Ocran Mattila, Phyllis, Ahmad, Rabbiya, Hasan, Syed Shahzad, Babar, Zaheer-Ud-Din |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120029/ https://www.ncbi.nlm.nih.gov/pubmed/33996712 http://dx.doi.org/10.3389/fpubh.2021.628744 |
Ejemplares similares
-
A comprehensive survey of cancer medicines prices, availability and affordability in Ghana
por: Ocran Mattila, Phyllis, et al.
Publicado: (2023) -
The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019) -
Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
por: Mattila, Phyllis Ocran, et al.
Publicado: (2021) -
Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
por: Babar, Zaheer Ud Din, et al.
Publicado: (2007) -
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)